What is the management and treatment of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management and Treatment of HELLP Syndrome

The definitive treatment for HELLP syndrome is prompt delivery after maternal stabilization, with immediate delivery indicated for patients with worsening pre-eclampsia, severe thrombocytopenia, deteriorating hepatic or renal function, gestational age ≥34 weeks, or evidence of fetal distress. 1

Diagnosis and Clinical Presentation

HELLP syndrome is characterized by:

  • Hemolysis (microangiopathic hemolytic anemia)
  • Elevated Liver enzymes (AST, ALT)
  • Low Platelets (<100,000/mm³)

Common clinical manifestations include:

  • Epigastric or right upper quadrant pain (cardinal symptom)
  • Nausea and vomiting
  • Malaise
  • Hypertension (absent in 20% of cases)
  • Proteinuria (minimal or absent in 5-15% of cases) 2

Management Algorithm

1. Initial Assessment and Stabilization

  • Laboratory investigations:

    • Complete blood count with platelet count
    • Liver function tests (AST, ALT, LDH)
    • Renal function tests
    • Coagulation profile (PT, PTT, fibrinogen, FDPs)
    • Peripheral blood smear for evidence of hemolysis
    • Serum haptoglobin (most sensitive marker for hemolysis) 1, 2
  • Additional monitoring:

    • Chest X-ray to exclude pulmonary edema
    • ECG examination
    • Urinary catheter for hourly output monitoring
    • Central venous pressure monitoring in critically ill patients 1

2. Blood Product Management

  • Platelet transfusion:

    • Administer if platelet count <50,000/mm³ for patients requiring Cesarean section 1
    • Higher vigilance for hepatic hemorrhage with platelet counts <20,000/mm³ 3
  • Blood transfusion:

    • Transfuse fresh whole blood if hemoglobin <10 g/dL 1

3. Blood Pressure Control

  • IV antihypertensive medications for severe hypertension:
    • IV labetalol: 10-20 mg initially, then 20-80 mg every 10-30 minutes
    • IV hydralazine: 5-10 mg every 15-30 minutes
    • IV nicardipine: starting at 5 mg/h, increasing by 2.5 mg/h every 5-15 minutes 3

4. Seizure Prophylaxis

  • Magnesium sulfate for all women with HELLP syndrome:
    • Loading dose: 4-5g IV over 15-20 minutes
    • Maintenance: 1-2g/hour continuous infusion 3

5. Delivery Decision-Making

  • Immediate delivery indicated for:

    • Gestational age ≥34 weeks
    • Worsening maternal condition (increasing hypertension, cerebral symptoms, deteriorating liver or kidney function)
    • Severe thrombocytopenia
    • Evidence of fetal distress 1, 3
  • For gestational age <34 weeks:

    • Consider expectant management only at centers with maternal-fetal medicine expertise
    • Close monitoring of maternal and fetal condition 3

6. Mode of Delivery

  • Vaginal delivery can be accomplished in most cases
  • Cesarean section rates are high (61.5-76%) due to obstetric indications 1, 4

7. Anesthetic Considerations

  • For platelet count >100,000/mm³:

    • Regional anesthesia (spinal or epidural) is preferred 5
  • For platelet count <50,000/mm³ or rapidly falling:

    • General anesthesia with careful airway management
    • Use drugs with minimal hepatic/renal metabolism
    • Consider propofol for induction (no active metabolites)
    • Suxamethonium for rapid sequence intubation 1, 5

8. Postpartum Management

  • Monitor in high-dependency or intensive care setting for at least 24-48 hours
  • Continue blood pressure monitoring every 4-6 hours for at least 3 days
  • Monitor laboratory parameters until normalization
  • Continue antihypertensive medications as needed and taper slowly after days 3-6 1, 3

Special Considerations and Pitfalls

  1. Differential diagnosis: HELLP syndrome can mimic other conditions such as acute fatty liver of pregnancy, thrombotic thrombocytopenic purpura (TTP), and hemolytic uremic syndrome (HUS). Careful evaluation is essential for correct diagnosis and management. 6

  2. Fluid management: Aim for euvolemia, not "running dry," as these patients are often relatively hypovolemic despite edema. 3

  3. Maternal glucose monitoring: Check blood glucose levels during operation as severe hypoglycemia has been reported in association with HELLP syndrome. 1

  4. Postpartum HELLP: Remember that up to 30% of HELLP syndrome cases occur postpartum, requiring vigilant monitoring even after delivery. 2

  5. Long-term follow-up: Schedule follow-up within 1 week if still on antihypertensives at discharge, and review at 3 months postpartum to ensure resolution of all abnormalities. 3

  6. Future pregnancy counseling: Advise patients about the 27-48% risk of recurrent hypertensive disorders in subsequent pregnancies. Consider prophylactic low-dose aspirin (150 mg) before 16 weeks' gestation in future pregnancies. 3, 2

HELLP syndrome is a life-threatening condition with a reported maternal mortality of 3.4%. Early recognition, prompt intervention, and delivery are crucial for improving maternal and fetal outcomes. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

HELLP syndrome.

Journal of perinatal medicine, 2000

Guideline

Preeclampsia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Care of the pregnancy complicated by HELLP syndrome.

Gastroenterology clinics of North America, 1992

Research

Anesthetic considerations in HELLP syndrome.

Acta anaesthesiologica Scandinavica, 2016

Research

HELLP Syndrome at 17 Weeks Gestation: A Rare and Catastrophic Phenomenon.

Journal of clinical gynecology and obstetrics, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.